Medical Condition News

RSS

Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

Stand Up To Cancer (SU2C), the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that the Allan H. (Bud) and Sue Selig Stand Up To Cancer Melanoma Innovative Research Grant Recipient Roger S. Lo, M.D., Ph.D., associate professor in the Department of Medicine at the Jonsson Comprehensive Cancer Center of the University of California, Los Angeles (UCLA) has published two studies in Cancer Discovery, a journal of the American Association for Cancer Research which indicate that treatment using combinatory therapy may be effective in suppressing drug resistance in the treatment of melanoma.

21 Nov 2013

Research: New drugs show ability to rapidly shrink melanoma tumors

Melanoma is the deadliest form of skin cancer, killing more than 8,000 in the U.S. each year. Approximately 40 percent of advanced melanoma tumors are driven to grow by the presence of mutations in a gene known as the BRAF gene.

21 Nov 2013

New technique can diagnose cancer with high degree of accuracy, say researchers

A team of researchers from UCLA and Harvard University have demonstrated a technique that, by measuring the physical properties of individual cells in body fluids, can diagnose cancer with a high degree of accuracy.

21 Nov 2013

New research highlights urgent need to address distress in long-term melanoma survivors

More than one-third of Queensland melanoma survivors are suffering clinically significant psychological distress, despite the high survival rate associated with the cancer.

21 Nov 2013

Study reveals benefits of bright light in treating anxiety

The bright light headset maker Valkee today announced the results of a new groundbreaking bright light study, showing statistically significant positive results in acutely alleviating anxiety symptoms. The world's first randomized, fully sham-controlled double blind trial of bright light treatment administered via ear canals brings sought-after new data to support the bright light studies carried out internationally since the 1980s.

21 Nov 2013

Kennedy Krieger Institute researchers find therapeutic benefits of virtual sailing

Researchers at the Kennedy Krieger Institute announced today the results of a pilot study demonstrating use of a virtual therapeutic sailing simulator as an important part of rehabilitation following a spinal cord injury. Published in the American Journal of Physical Medicine & Rehabilitation, findings show that using a hands-on sailing simulator over a 12-week period helped participants safely learn sailing skills in a controlled environment, ultimately improving their quality of life by gaining the ability to participate in a recreational sport.

21 Nov 2013

Safest way to manage brain AVM is to treat patient's symptoms only

Patients with a condition that causes blood vessels in the brain to form an abnormal tangle could be helped by the findings of new research.

21 Nov 2013

Mitral valve replacement may provide better long-term correction of mitral regurgitation

The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation -- mitral valve repair and mitral valve replacement.

21 Nov 2013

Vagus nerve stimulation-tone therapy safe for treating tinnitus, say UT Dallas researchers

UT Dallas researchers have demonstrated that treating tinnitus, or ringing in the ears, using vagus nerve stimulation-tone therapy is safe and brought significant improvement to some of the participants in a small clinical trial.

21 Nov 2013

Buck Institute research provides method to study sarcopenia

Our epigenome is a set of chemical switches that turn parts of our genome off and on at strategic times and locations. These switches help alter the way our cells act and are impacted by environmental factors including diet, exercise and stress. Research at the Buck Institute reveals that aging also effects the epigenome in human skeletal muscle. The study, appearing on line in Aging Cell, provides a method to study sarcopenia, the degenerative loss of muscle mass that begins in middle age.

21 Nov 2013

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

In what are believed to be the first studies of their kind, Cedars-Sinai researchers recording the real-time firing of individual nerve cells in the brain found that a specific type of neuron in a structure called the amygdala performed differently in people who suffer from autism spectrum disorder than in those who do not.

21 Nov 2013

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Because of its participation in a pivotal trial, Henry Ford Hospital will be the first in Michigan to offer electric stimulation of the brain using a newly FDA-approved device for hard-to-treat epilepsy cases.

21 Nov 2013

Smoking influences survival of nasopharyngeal carcinoma patients

Survivors of nasopharyngeal carcinoma who are former or current smokers are more likely to have their disease progress, relapse, or spread, and are more likely to die of their disease, compared with survivors of nasopharyngeal carcinoma who have never smoked, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

21 Nov 2013

Multiple sclerosis researchers receive NMSS drug development grant

A $500,000 drug development grant from the National Multiple Sclerosis Society was awarded to a partnership between a multiple sclerosis research team at the Icahn School of Medicine at Mount Sinai and Karyopharm Therapeutics Inc., a clinical stage pharmaceutical company. Dr. Patrizia Casaccia, MD, PhD, Professor in the Departments of Neuroscience and Genetics and Genomics, at Icahn School of Medicine at Mount Sinai, will be the academic lead.

21 Nov 2013

Changing texture can make bread taste salty even if salt content is reduced, say scientists

Want to make bread taste pleasantly salty without adding more salt? Change the bread's texture so it is less dense, say scientists. They report in ACS' Journal of Agricultural and Food Chemistry that simply making the pores, or holes, larger can make people perceive bread as having saltier taste.

21 Nov 2013

Released prisoners with schizophrenia three times more likely to be violent than other prisoners

New research from Queen Mary University of London shows released prisoners with schizophrenia are three times more likely to be violent than other prisoners, but only if they receive no treatment or follow-up support from mental health services.

21 Nov 2013

Smokers who quit faster may be able to lower risk of cardiovascular disease-related deaths

Cigarette smokers who are over 65 years of age may be able to lower their risk of cardiovascular disease-related deaths to the level of never-smokers when they quit faster than previously reported, according to research presented at the American Heart Association's Scientific Sessions 2013.

21 Nov 2013

Study finds high rate of anisometropia in older adults

Follow-up in older adults shows a high rate of anisometropia, or differing levels of visual abnormalities between eyes, reports a study in Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 Nov 2013

Chicago Stroke Trials Consortium to build infrastructure to support clinical trials for stroke prevention

A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine-, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital of Cook County, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery.

21 Nov 2013

UK's first gene therapy trial for patients with chronic heart failure begins at GJNH

The UK’s first gene therapy trial for advanced heart failure, CUPID 2, has officially begun at the Golden Jubilee National Hospital; with the first candidate recently being administered with a dose of the MYDICAR treatment.

21 Nov 2013

Medical Condition News

Combinatory therapy may be effective in suppressing drug resistance in treatment of melanoma

Research: New drugs show ability to rapidly shrink melanoma tumors

New technique can diagnose cancer with high degree of accuracy, say researchers

New research highlights urgent need to address distress in long-term melanoma survivors

Study reveals benefits of bright light in treating anxiety

Kennedy Krieger Institute researchers find therapeutic benefits of virtual sailing

Safest way to manage brain AVM is to treat patient's symptoms only

Mitral valve replacement may provide better long-term correction of mitral regurgitation

Vagus nerve stimulation-tone therapy safe for treating tinnitus, say UT Dallas researchers

Buck Institute research provides method to study sarcopenia

Cedars-Sinai study presents new insights into mechanisms underlying the symptoms of autism

Henry Ford offers electric stimulation of brain using FDA-approved device for hard-to-treat epilepsy cases

Smoking influences survival of nasopharyngeal carcinoma patients

Multiple sclerosis researchers receive NMSS drug development grant

Changing texture can make bread taste salty even if salt content is reduced, say scientists

Released prisoners with schizophrenia three times more likely to be violent than other prisoners

Smokers who quit faster may be able to lower risk of cardiovascular disease-related deaths

Study finds high rate of anisometropia in older adults

Chicago Stroke Trials Consortium to build infrastructure to support clinical trials for stroke prevention

UK's first gene therapy trial for patients with chronic heart failure begins at GJNH

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News